beta-D-Galp-(1->4)-[beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)]-beta-D-GlcpNAc

Term ID

CHEBI:61841

Synonyms

beta-D-Gal-(1->4)-[beta-D-Gal-(1->4)-beta-D-Glc-(1->6)]-beta-D-GlcNAc
beta-D-Gal-(1->4)-beta-D-Glc-(1->6)-[beta-D-Gal-(1->4)]-beta-D-GlcNAc
beta-D-galactopyranosyl-(1->4)-[beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->6)]-2-acetamido-2-deoxy-beta-D-glucopyranose
beta-D-galactosyl-(1->4)-[beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1->6)]-N-acetyl-beta-D-glucosamine
beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1->6)-[beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosamine
beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc
Galbeta1-4(Galbeta1-4Glcbeta1-6)GlcNAcbeta
Galbeta1-4Glcbeta1-6(Galbeta1-4)GlcNAcbeta

Definition

A branched amino tetrasaccharide comprising N-acetyl-β-D-glucosamine at the reducing end with a β-D-galactosyl group attached at the 4-position and a β-D-galactosyl-(1→4)-β-D-glucosyl moiety at the 6-position.

References

glygen:G09494DM
glytoucan:G09494DM
pubmed:18678667
pubmed:30788740

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->4)-[beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)]-beta-D-GlcpNAc

Phenotype where environments contain beta-D-Galp-(1->4)-[beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)]-beta-D-GlcpNAc

Phenotype modified by environments containing beta-D-Galp-(1->4)-[beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)]-beta-D-GlcpNAc

Phenotype affecting beta-D-Galp-(1->4)-[beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)]-beta-D-GlcpNAc

Human Disease Model